不能平庸 发表于 2025-3-21 17:33:03

书目名称Bone Metastases影响因子(影响力)<br>        http://impactfactor.cn/if/?ISSN=BK0189688<br><br>        <br><br>书目名称Bone Metastases影响因子(影响力)学科排名<br>        http://impactfactor.cn/ifr/?ISSN=BK0189688<br><br>        <br><br>书目名称Bone Metastases网络公开度<br>        http://impactfactor.cn/at/?ISSN=BK0189688<br><br>        <br><br>书目名称Bone Metastases网络公开度学科排名<br>        http://impactfactor.cn/atr/?ISSN=BK0189688<br><br>        <br><br>书目名称Bone Metastases被引频次<br>        http://impactfactor.cn/tc/?ISSN=BK0189688<br><br>        <br><br>书目名称Bone Metastases被引频次学科排名<br>        http://impactfactor.cn/tcr/?ISSN=BK0189688<br><br>        <br><br>书目名称Bone Metastases年度引用<br>        http://impactfactor.cn/ii/?ISSN=BK0189688<br><br>        <br><br>书目名称Bone Metastases年度引用学科排名<br>        http://impactfactor.cn/iir/?ISSN=BK0189688<br><br>        <br><br>书目名称Bone Metastases读者反馈<br>        http://impactfactor.cn/5y/?ISSN=BK0189688<br><br>        <br><br>书目名称Bone Metastases读者反馈学科排名<br>        http://impactfactor.cn/5yr/?ISSN=BK0189688<br><br>        <br><br>

Cognizance 发表于 2025-3-21 20:44:18

Pathophysiology of Bone Metastasesindividually targeted in the clinic. However, inhibition of bone resorption is invariably effective and may oppose the initial development of cancer in bone. Central pathways, such as hypoxia and TGFβ signaling, are important for both tumor and bone functions; they are promising targets for improved

马赛克 发表于 2025-3-22 02:57:11

http://reply.papertrans.cn/19/1897/189688/189688_3.png

Gyrate 发表于 2025-3-22 06:10:45

Nuclear Medicine Imaging Modalities: Bone Scintigraphy, PET-CT, SPECT-CTrtain cancer type. Recent development in soft- and hard-ware led to the introduction of hybrid camera systems (SPECT-CT and PET-CT), combining (patho)physiology and anatomy together, leading to better diagnostic results and many advantages, also for the patient..In this chapter the basic principles

比喻好 发表于 2025-3-22 09:01:06

Bone Biomarkers in Research and Clinical Practicee in clinical practice. In this chapter, we review the bone biomarkers associated with bone turnover and consider the evidence from clinical studies for their potential in the future management of patients with metastatic bone disease.

seduce 发表于 2025-3-22 12:54:38

http://reply.papertrans.cn/19/1897/189688/189688_6.png

nuclear-tests 发表于 2025-3-22 17:22:05

Analgesic Treatment of Bone Metastasess showing lytic, sclerotic or mixed metastases, according to the primary tumour. The release of chemical mediators, the increased pressure within the bone, microfractures, the stretching of periosteum, reactive muscle spasm, nerve root infiltration and compression of nerves by the collapse of verteb

豪华 发表于 2025-3-22 23:01:43

Radionuclide Therapyions, patient selection, efficacy, and different biochemical characteristics and toxicity. We will cover Strontium-89 chloride (Sr-89), Samarium-153 lexidronam (Sm-153) and Rhenium-186 etidronate (Re-186). A brief discussion on the available data on Rhenium-188 (Re-188) is also presented focusing on

相反放置 发表于 2025-3-23 04:08:02

New Targeted Therapies for Bone Metastases lung cancer. Also currently in development are numerous targeted agents that impact the function of the various growth factors released from the bone matrix that stimulate tumor growth, bone destruction, and lead to bone metastases.

Creditee 发表于 2025-3-23 08:21:17

http://reply.papertrans.cn/19/1897/189688/189688_10.png
页: [1] 2 3 4 5 6
查看完整版本: Titlebook: Bone Metastases; A translational and Vassilios Vassiliou,Edward Chow,Dimitrios Kardamak Book 2014Latest edition Springer Science+Business